The Indianapolis-based company said Wednesday that its newest product, a drug for obesity called Zepbound, will be on pharmacy shelves shortly after Thanksgiving. The company is ramping up manufacturing capacity to avoid possible shortages and to meet potentially huge demand in a nation where more than 40% of adults are classified as obese.... Read More
Community Health Network has socked away $75 million in a “potential settlement agreement” with the U.S. Justice Department and a former chief financial officer who filed a whistleblower suit nearly a decade ago.... Read More
Excluding nonrecurring items, the Indianapolis-based drugmaker posted adjusted earnings of 10 cents a share, beating Zacks consensus estimate of a loss of 11 cents a share.... Read More
Indiana University announced Monday afternoon that it plans to invest more than $250 million to create two new science and health research institutes in Indianapolis, recruit life-sciences researchers to Bloomington, and expand or renovate laboratory space at both campuses.... Read More
Therapy dogs, a growing area of patient care, are specially trained and certified dogs who visit hospitals, clinics and nursing homes with their owners, and provide comfort and support to people in stressful or anxious situations.... Read More
Indiana University Health Foundation, the fundraising arm of IU Health’s adult hospitals, is launching a $200 million fundraising campaign with the ambitious goal of making Indiana one of the healthiest states in the country.... Read More
Indiana’s life sciences advocates say the state’s new designation as a federal technology hub will position it to compete for millions of dollars and boost the state’s image as a biotech innovator.... Read More
A Texas woman has agreed to plead guilty to leading a conspiracy to defraud Indianapolis-based drugmaker Eli Lilly and Co. out of more than $600,000 in false prescription savings cards.... Read More
Top executives and directors of Indianapolis-based Point Biopharma Global Inc. could rake in an eye-popping $212 million from their deal to sell the company to drugmaker Eli Lilly and Co. Some could also reap millions more in severance pay and stock options.... Read More
In just a few months, Shawn Fain has gone from obscurity to one of the most visible leaders in America, pulling, cajoling, demanding that his workers get more concessions from the Big Three automakers after two decades of givebacks.... Read More
